chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Neck pain, Pain in extremity
Clinical narrative: Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Headache since she woke up this morning; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) and the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Atrial fibrillation.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache since she woke up this morning). On an unknown date, the patient experienced ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the last episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Hurting all over, neck, arms, shoulder, legs; Feels tired, sluggish; Headache since she woke up this morning; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) and the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension and Atrial fibrillation.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced HEADACHE (Headache since she woke up this morning). On an unknown date, the patient experienced ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the first episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), the second episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, HEADACHE (Headache since she woke up this morning), ARTHRALGIA (Hurting all over, neck, arms, shoulder, legs), FATIGUE (Feels tired, sluggish), the last episode of PAIN IN EXTREMITY (Hurting all over, neck, arms, shoulder, legs), NECK PAIN (Hurting all over, neck, arms, shoulder, legs) and SLUGGISHNESS (Feels tired, sluggish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information, if any, was not provided by the reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: pain in shin bone/hurt from left ankle to hip; could not walk or stand on foot; A spontaneous report was received from a consumer concerning a 78-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in shin bone, could not walk or stand on foot, hurt from left ankle to hip.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 023M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event(s) pain in shin bone, could not walk or stand on foot, hurt from left ankle to hip.  Treatment details included Tylenol, Morphine.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pain in shin bone, could not walk or stand on foot, hurt from left ankle to hip was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pruritus, Rash, Rash macular
Clinical narrative: Skin now blotchy and flaky; Welps all over body; Delayed Rash all over body; Felt dizzy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy), RASH MACULAR (Skin now blotchy and flaky) and PRURITUS (Welps all over body) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy) and PRURITUS (Welps all over body). On 22-Feb-2021, the patient experienced RASH MACULAR (Skin now blotchy and flaky). The patient was treated with PREDNISONE for Adverse event, at an unspecified dose and frequency; TRIAMCINOLONE for Adverse event, at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (Delayed Rash all over body), DIZZINESS (Felt dizzy), RASH MACULAR (Skin now blotchy and flaky) and PRURITUS (Welps all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not reported  Treatment : Steroid shot by primary care doctor
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Headache, Myalgia
Clinical narrative: Tiredness and with no energy; All the body was shaking; Blurry vision; Cough; Nausea; Fever; Headaches; body aches; Chills; Red eyes; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough) and OCULAR HYPERAEMIA (Red eyes) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced OCULAR HYPERAEMIA (Red eyes). On 27-Feb-2021, the patient experienced ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough), NAUSEA (Nausea), PYREXIA (Fever), HEADACHE (Headaches), MYALGIA (body aches) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough), NAUSEA (Nausea), PYREXIA (Fever), HEADACHE (Headaches), MYALGIA (body aches) and CHILLS (Chills) had resolved and OCULAR HYPERAEMIA (Red eyes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.     Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: updated vaccine information( dose 2).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Ocular hyperaemia, Pyrexia, Tremor, Vision blurred
Clinical narrative: Tiredness and with no energy; All the body was shaking; Blurry vision; Cough; Nausea; Fever; Headaches; body aches; Chills; Red eyes; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough) and OCULAR HYPERAEMIA (Red eyes) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced OCULAR HYPERAEMIA (Red eyes). On 27-Feb-2021, the patient experienced ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough), NAUSEA (Nausea), PYREXIA (Fever), HEADACHE (Headaches), MYALGIA (body aches) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Tiredness and with no energy), TREMOR (All the body was shaking), VISION BLURRED (Blurry vision), COUGH (Cough), NAUSEA (Nausea), PYREXIA (Fever), HEADACHE (Headaches), MYALGIA (body aches) and CHILLS (Chills) had resolved and OCULAR HYPERAEMIA (Red eyes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.     Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: updated vaccine information( dose 2).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Pyrexia
Clinical narrative: headache; ow grade temperature; joint pain and ache in knee; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (ow grade temperature) and ARTHRALGIA (joint pain and ache in knee) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (headache). 27-Feb-2021, the patient experienced PYREXIA (ow grade temperature) and ARTHRALGIA (joint pain and ache in knee). At the time of the report, HEADACHE (headache), PYREXIA (ow grade temperature) and ARTHRALGIA (joint pain and ache in knee) had resolved.            The action taken with the drug was Not applicable. concomitant medications are not provided.   This case was linked to MOD-2021-030659 (Patient Link).
Age: 69.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: chills; temperature of 102 degrees F; headache; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (temperature of 102 degrees F), HEADACHE (headache) and MYALGIA (muscle aches) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]), ROSUVASTATIN CALCIUM (CRESTOR), CLOPIDOGREL BISULFATE (PLAVIX), METOPROLOL SUCCINATE (TOPROL), MULTIVITAMIN [VITAMINS NOS], FISH OIL, UBIDECARENONE (COQ), ACETYLSALICYLIC ACID (BABY ASPIRIN) and CALCIUM for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced CHILLS (chills), PYREXIA (temperature of 102 degrees F), HEADACHE (headache) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 13-Feb-2021, CHILLS (chills), PYREXIA (temperature of 102 degrees F), HEADACHE (headache) and MYALGIA (muscle aches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-030499.; Sender's Comments:  MOD-2021-030499:crosslink
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Dizziness, Myalgia, Nausea
Clinical narrative: dizzy; vomited; nausea; chills; cold sweat; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), VOMITING (vomited), NAUSEA (nausea), CHILLS (chills) and COLD SWEAT (cold sweat) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (dizzy), VOMITING (vomited), NAUSEA (nausea), CHILLS (chills), COLD SWEAT (cold sweat) and MYALGIA (muscle aches). On 27-Feb-2021, VOMITING (vomited) had resolved. On 28-Feb-2021, MYALGIA (muscle aches) had resolved. At the time of the report, DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (chills) and COLD SWEAT (cold sweat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: dizzy; vomited; nausea; chills; cold sweat; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), VOMITING (vomited), NAUSEA (nausea), CHILLS (chills) and COLD SWEAT (cold sweat) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (dizzy), VOMITING (vomited), NAUSEA (nausea), CHILLS (chills), COLD SWEAT (cold sweat) and MYALGIA (muscle aches). On 27-Feb-2021, VOMITING (vomited) had resolved. On 28-Feb-2021, MYALGIA (muscle aches) had resolved. At the time of the report, DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (chills) and COLD SWEAT (cold sweat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Rash, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: rash on her arms and legs; redness spread down to her elbow; injection site started to turn birght red; arm on injection site swelled a bit; felt warm; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site started to turn birght red), VACCINATION SITE SWELLING (arm on injection site swelled a bit), VACCINATION SITE WARMTH (felt warm), ERYTHEMA (Redness) and RASH (rash on her arms and legs) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site started to turn birght red), VACCINATION SITE SWELLING (arm on injection site swelled a bit), VACCINATION SITE WARMTH (felt warm) and ERYTHEMA (Redness). On 06-Feb-2021, the patient experienced ERYTHEMA (redness spread down to her elbow). On 07-Feb-2021, the patient experienced RASH (rash on her arms and legs). On 08-Feb-2021, VACCINATION SITE SWELLING (arm on injection site swelled a bit) and VACCINATION SITE WARMTH (felt warm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection site started to turn birght red), ERYTHEMA (Redness), RASH (rash on her arms and legs) and ERYTHEMA (redness spread down to her elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: some pain; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and PAIN (some pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced HERPES ZOSTER (Shingles). On an unknown date, the patient experienced PAIN (some pain). At the time of the report, HERPES ZOSTER (Shingles) outcome was unknown and PAIN (some pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication and treatment information were not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Depression, Rash, Rash macular
Clinical narrative: anxiety; depression; rash; red blotch; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash), RASH MACULAR (red blotch), ANXIETY (anxiety) and DEPRESSION (depression) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for an unknown indication.     The patient's past medical history included Parkinson's disease (Takes Carbidopa/levodopa 2 25/100 mg tablets thrice a day.). Concomitant products included TRAZODONE for Anxiety depression, CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA) for Parkinson's disease.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (rash) and RASH MACULAR (red blotch). On an unknown date, the patient experienced ANXIETY (anxiety) and DEPRESSION (depression). At the time of the report, RASH (rash), RASH MACULAR (red blotch), ANXIETY (anxiety) and DEPRESSION (depression) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (Headache). On 25-Feb-2021, HEADACHE (Headache) had resolved. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: redness around the injection site; swollen around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness around the injection site) and INJECTION SITE SWELLING (swollen around the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), SPIRONOLACTONE, METOPROLOL SUCCINATE (TOPROL) and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness around the injection site) and INJECTION SITE SWELLING (swollen around the injection site). At the time of the report, INJECTION SITE ERYTHEMA (redness around the injection site) and INJECTION SITE SWELLING (swollen around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment include: allergy reliefs called top care
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: dizziness; severe exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (severe exhaustion) and DIZZINESS (dizziness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (she previously had Covid-19 and already had antibodies.).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (severe exhaustion). On 27-Feb-2021, the patient experienced DIZZINESS (dizziness). On 27-Feb-2021, FATIGUE (severe exhaustion) had resolved. At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chills, Fatigue, Hypertension, Urticaria
Clinical narrative: blood pressure went up to 157/80; Bad hives; Chills; Very tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (blood pressure went up to 157/80), URTICARIA (Bad hives), CHILLS (Chills) and FATIGUE (Very tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills) and FATIGUE (Very tired). On 27-Feb-2021, the patient experienced URTICARIA (Bad hives). On an unknown date, the patient experienced HYPERTENSION (blood pressure went up to 157/80). On 28-Feb-2021, URTICARIA (Bad hives) had resolved. At the time of the report, HYPERTENSION (blood pressure went up to 157/80), CHILLS (Chills) and FATIGUE (Very tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 157/80 mmHg (High) when she was seen at the yearly check up..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications included aspirin.   Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: Added medically confirmed to yes, lab data and new event.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Limb discomfort, Pyrexia, Vaccination site scar
Clinical narrative: Curious phenomenon on my arm now; Divot/cavity where shit was given; Fever; A little alien In my stomach running around; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (A little alien In my stomach running around), LIMB DISCOMFORT (Curious phenomenon on my arm now), VACCINATION SITE SCAR (Divot/cavity where shit was given) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L2OA) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (A little alien In my stomach running around) and PYREXIA (Fever). On an unknown date, the patient experienced LIMB DISCOMFORT (Curious phenomenon on my arm now) and VACCINATION SITE SCAR (Divot/cavity where shit was given). At the time of the report, ABDOMINAL DISCOMFORT (A little alien In my stomach running around), LIMB DISCOMFORT (Curious phenomenon on my arm now), VACCINATION SITE SCAR (Divot/cavity where shit was given) and PYREXIA (Fever) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up received: added events.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: arm soreness; swolling at the injection site; redness at the injection site; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm soreness), VACCINATION SITE SWELLING (swolling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm soreness), VACCINATION SITE SWELLING (swolling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 09-Jan-2021, VACCINATION SITE PAIN (arm soreness), VACCINATION SITE SWELLING (swolling at the injection site), VACCINATION SITE ERYTHEMA (redness at the injection site) and VACCINATION SITE PRURITUS (itching at the injection site) had resolved.            This case was linked to MOD-2021-062431 (Patient Link).   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Paraesthesia, Swelling face
Clinical narrative: face started tingling; face started swelling; lip was swollen; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face started swelling), LIP SWELLING (lip was swollen) and PARAESTHESIA (face started tingling) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced SWELLING FACE (face started swelling) and LIP SWELLING (lip was swollen). On 09-Feb-2021, the patient experienced PARAESTHESIA (face started tingling). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Tingling, at an unspecified dose and frequency. At the time of the report, SWELLING FACE (face started swelling), LIP SWELLING (lip was swollen) and PARAESTHESIA (face started tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Patient reported that she experienced face tingling on 09-FEB-2021 and 26-FEB-2021.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow-up received on 20-JUL-2021 and reporter information was updated
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia
Clinical narrative: Pains at lower stomach; hips pain; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Pains at lower stomach) and ARTHRALGIA (hips pain) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Pains at lower stomach) and ARTHRALGIA (hips pain). At the time of the report, ABDOMINAL PAIN UPPER (Pains at lower stomach) and ARTHRALGIA (hips pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm pain; Fatigue and tiredness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (Sore arm pain) and FATIGUE (Fatigue and tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In January 2021, the patient experienced PAIN IN EXTREMITY (Sore arm pain) and FATIGUE (Fatigue and tiredness). At the time of the report, PAIN IN EXTREMITY (Sore arm pain) and FATIGUE (Fatigue and tiredness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication were provided no treatment information were provided   Reporter did not allow further contact
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vaccination site bruising, Vaccination site erythema, Vaccination site pain
Clinical narrative: Nausea; Headache; Red area at site of injection; Raised area at site of injection ~3 inches long; Bruising at the site of injection; Arm pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain at the site of injection), NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection) and VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), VITAMIN D NOS, PROBIOTICS NOS, BECLOMETASONE DIPROPIONATE (QVAR) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm pain at the site of injection). On 28-Feb-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection), VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) and VACCINATION SITE BRUISING (Bruising at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm pain at the site of injection), NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection), VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) and VACCINATION SITE BRUISING (Bruising at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Nausea; Headache; Red area at site of injection; Raised area at site of injection ~3 inches long; Bruising at the site of injection; Arm pain at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm pain at the site of injection), NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection) and VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), VITAMIN D NOS, PROBIOTICS NOS, BECLOMETASONE DIPROPIONATE (QVAR) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm pain at the site of injection). On 28-Feb-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection), VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) and VACCINATION SITE BRUISING (Bruising at the site of injection). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm pain at the site of injection), NAUSEA (Nausea), HEADACHE (Headache), VACCINATION SITE ERYTHEMA (Red area at site of injection), VACCINATION SITE SWELLING (Raised area at site of injection ~3 inches long) and VACCINATION SITE BRUISING (Bruising at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: metallic taste in mouth; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (metallic taste in mouth) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and FAMOTIDINE for an unknown indication.    On 15-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth). At the time of the report, DYSGEUSIA (metallic taste in mouth) outcome was unknown.            Treatment : Mouth rinse from dentist
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Muscle tightness, Pain in extremity, Vaccination site discolouration, Vaccination site erythema
Clinical narrative: shoulder and arm began to experience some pain; shoulder and arm began to experience some pain; Tightness; Red and White Spot; Red and White Spot; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder and arm began to experience some pain), PAIN IN EXTREMITY (shoulder and arm began to experience some pain), MUSCLE TIGHTNESS (Tightness), VACCINATION SITE ERYTHEMA (Red and White Spot) and VACCINATION SITE DISCOLOURATION (Red and White Spot) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L208) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder and arm began to experience some pain), PAIN IN EXTREMITY (shoulder and arm began to experience some pain), MUSCLE TIGHTNESS (Tightness), VACCINATION SITE ERYTHEMA (Red and White Spot) and VACCINATION SITE DISCOLOURATION (Red and White Spot). At the time of the report, ARTHRALGIA (shoulder and arm began to experience some pain), PAIN IN EXTREMITY (shoulder and arm began to experience some pain) and MUSCLE TIGHTNESS (Tightness) outcome was unknown and VACCINATION SITE ERYTHEMA (Red and White Spot) and VACCINATION SITE DISCOLOURATION (Red and White Spot) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment : Cold compress
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Injection site warmth, Migraine, Pain in extremity
Clinical narrative: Tiny little bumps; Warm to the touch; Red circle; Swollen; Horrific migraine; Chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Tiny little bumps) and INJECTION SITE WARMTH (Warm to the touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension, Atrial fibrillation and Arthritis.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen), ERYTHEMA (Tiny little bumps), INJECTION SITE WARMTH (Warm to the touch) and ERYTHEMA (Red circle). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Tiny little bumps), INJECTION SITE WARMTH (Warm to the touch) and ERYTHEMA (Red circle) outcome was unknown.            Concomitant medications included high blood pressure medicine and blood thinner.   This case was linked to MOD-2021-030349, MOD-2021-030349 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Tiny little bumps; Warm to the touch; Red circle; Swollen; Horrific migraine; Chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Horrific migraine), PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Tiny little bumps) and INJECTION SITE WARMTH (Warm to the touch) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 02SL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension, Atrial fibrillation and Arthritis.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 26-Feb-2021, the patient experienced MIGRAINE (Horrific migraine) and CHILLS (Chills). On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen), ERYTHEMA (Tiny little bumps), INJECTION SITE WARMTH (Warm to the touch) and ERYTHEMA (Red circle). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 26-Feb-2021, MIGRAINE (Horrific migraine) had resolved. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Tiny little bumps), INJECTION SITE WARMTH (Warm to the touch) and ERYTHEMA (Red circle) outcome was unknown.            Concomitant medications included high blood pressure medicine and blood thinner.   This case was linked to MOD-2021-030349, MOD-2021-030349 (Patient Link).
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Incredibly tired; Had chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Incredibly tired) and CHILLS (Had chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M204B) for COVID-19 vaccination.     Concurrent medical conditions included Obesity.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced FATIGUE (Incredibly tired) and CHILLS (Had chills). On 27-Feb-2021, FATIGUE (Incredibly tired) and CHILLS (Had chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 with the events was considered as not applicable  concomitant medicines was not reported by reporter   Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Fallow up received on 30-apr-21 contains no new information
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site pain, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: Swelling in the arm; Sore; Big red blotch formed below the injection site; itching; Hives; A lot of redness; Tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Sore), RASH MACULAR (Big red blotch formed below the injection site), PRURITUS (itching) and URTICARIA (Hives) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Sore), RASH MACULAR (Big red blotch formed below the injection site), PRURITUS (itching), URTICARIA (Hives), ERYTHEMA (A lot of redness) and INJECTION SITE PAIN (Tender to touch). At the time of the report, PERIPHERAL SWELLING (Swelling in the arm), PAIN IN EXTREMITY (Sore), RASH MACULAR (Big red blotch formed below the injection site), PRURITUS (itching), URTICARIA (Hives), ERYTHEMA (A lot of redness) and INJECTION SITE PAIN (Tender to touch) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up information received on 20-Jul-2021 and included Outcome of all the events were updated from unknown to recovered.